Aktis Oncology, Inc. Common stock (AKTS)
Healthcare
Biotechnology
22.20 $
+0.7%
vs. previous close
Closing price · As of: 3. Aug 2026
Aktis Oncology, Inc. Common stock (AKTS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -24 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q3 24 | Q4 24 | Q1 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -15 | -11 | -9.9 | -8.7 | -13 | -11 | -7.8 | -12 | -13 | -17 | -15 | -24 | |
| 2.5 | 2.7 | 3.2 | 3.2 | 3.1 | 3.3 | 3.4 | 1.3 | 0.4 | 0.5 | 0.7 | 0.7 | |
| 2.3 | 1.9 | 3.2 | 2.0 | 1.9 | 0.3 | 0.9 | -1.7 | 1.1 | 1.2 | 1.1 | 3.0 | |
| -1.4 | -3.8 | 1.5 | 3.0 | 3.8 | -1.0 | 3.0 | -5.6 | -0.6 | -2.4 | -1.2 | -9.1 | |
| 4.8 | 3.2 | 2.2 | 1.2 | 4.2 | 1.6 | 0.3 | 0.1 | 2.2 | 1.9 | 4.2 | 1.9 | |
| -4.8 | -3.2 | -16 | -1.2 | -4.2 | -1.6 | -0.3 | -0.2 | -173 | – | -126 | 21 | |
| – | 0.3 | 32 | 0.3 | – | 0.1 | 10 | 17 | -1.8 | -0.5 | -0.8 | 338 | |
| -20 | -14 | 6.2 | -9.6 | -17 | -13 | 2.3 | -12 | -187 | 21 | -142 | 334 | |
| -20 | -14 | -12 | -9.9 | -17 | -13 | -8.1 | -12 | -15 | -19 | -19 | -26 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.